|
TMEM85 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.204000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.362400E-01 |
| Normal-vs-Stage2 |
8.918800E-01 |
| Normal-vs-Stage3 |
8.003200E-01 |
| Normal-vs-Stage4 |
6.461800E-01 |
| Stage1-vs-Stage2 |
6.020000E-01 |
| Stage1-vs-Stage3 |
8.608200E-01 |
| Stage1-vs-Stage4 |
9.031400E-01 |
| Stage2-vs-Stage3 |
7.120800E-01 |
| Stage2-vs-Stage4 |
6.077600E-01 |
| Stage3-vs-Stage4 |
8.096000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.488000E-01 |
| Normal-vs-AfricanAmerican |
2.236200E-01 |
| Normal-vs-Asian |
3.672600E-01 |
| Caucasian-vs-AfricanAmerican |
1.285640E-01 |
| Caucasian-vs-Asian |
6.432800E-01 |
| AfricanAmerican-vs-Asian |
7.152100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.627000E-01 |
| Normal-vs-Female |
6.506200E-01 |
| Male-vs-Female |
6.472200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.157800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.201200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.834400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.320600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.439600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.392600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.748800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.271600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.411400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.148400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.947000E-01 |
| Classical-VS-Follicular |
4.376600E-01 |
| Classical-VS-Other |
8.553000E-01 |
| Classical-VS-Normal |
9.248800E-01 |
| Tall-VS-Follicular |
7.916600E-01 |
| Tall-VS-Other |
9.659800E-01 |
| Tall-VS-Normal |
8.680000E-01 |
| Follicular-VS-Other |
8.476600E-01 |
| Follicular-VS-Normal |
5.735400E-01 |
| Other-VS-Normal |
8.721000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.933000E-01 |
| Normal-vs-N1 |
7.543000E-01 |
| N0-vs-N1 |
8.895800E-01 |
|
|
